Growth Direct System Workshop - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Growth Direct™ System Workshop

During this event, attendees will interact with the Growth Direct™ System and applications including sterility, environmental monitoring, water and bioburden testing. Representatives of Rapid Micro Biosystems will discuss technical data, difficult to handle samples, and will review the validation approach. The event includes a live demonstration of the Growth Direct System.

The Growth Direct™ System uses proprietary digital imaging technology that automatically enumerates microcolonies days earlier than the traditional visual plate counting methods. The system captures the native fluorescence (autofluorescence) that is emitted by all living cells. By detecting microcolonies composed of a small number of cells, the Growth Direct test can start to detection microbial growth in a matter of hours with final results in half the time of the traditional, visual methods. Because the test is non-destructive, colonies are available for identification without the need for a re-culture step.

To register for the 17 October event, click on the registration link:

Contact Details:

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
FindPharma Custom Search

Click here